4SC AG Рыночная капитализация
Что обозначает Рыночная капитализация в 4SC AG?
Рыночная капитализация 4SC AG является $73.02M
Какое определение для Рыночная капитализация?
Рыночная капитализация - это рыночная стоимость в тот момент времени, когда акции, находящиеся в обращении публичной компании, равна цене акций в тот отрезок времени, умноженной на количество акций в обращении .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Рыночная капитализация компаний в Health Care сектор на XETRA по сравнению с 4SC AG
Что делает 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Компании с рыночная капитализация похож на 4SC AG
- Pimco New York Municipal Income Fund имеет Рыночная капитализация из $72.86M
- Coventry Ltd имеет Рыночная капитализация из $72.93M
- Australian Pacific Coal имеет Рыночная капитализация из $72.94M
- Msl Soltns Fpo имеет Рыночная капитализация из $72.97M
- GAN имеет Рыночная капитализация из $72.99M
- Eleco Plc имеет Рыночная капитализация из $73.00M
- 4SC AG имеет Рыночная капитализация из $73.02M
- Quicklogic Corp имеет Рыночная капитализация из $73.04M
- Sbf Ag имеет Рыночная капитализация из $73.06M
- King's Flair International () имеет Рыночная капитализация из $73.12M
- Maxicity имеет Рыночная капитализация из $73.19M
- Permanent Magnets имеет Рыночная капитализация из $73.21M
- HCL Infosystems имеет Рыночная капитализация из $73.21M